The Enterprise Value as of November 2024 (TTM) for Annexon, Inc. (ANNX) is 513.95M

According to Annexon, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 513.95M. This represents a change of -4.92% compared to the average of 540.52M of the last 4 quarters.

Annexon, Inc. (ANNX) Historical Enterprise Value (quarterly & annually)

How has ANNX Enterprise Value performed in the past?

The mean historical Enterprise Value of Annexon, Inc. over the last ten years is 358.20M. The current 513.95M Enterprise Value has changed 14.25% with respect to the historical average. Over the past ten years (40 quarters), ANNX's Enterprise Value was at its highest in in the March 2021 quarter at 855.79M. The Enterprise Value was at its lowest in in the December 2018 quarter at -31362680.00.

Annexon, Inc. (ANNX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Annexon, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Annexon, Inc. (ANNX) Average Enterprise Value

How has ANNX Enterprise Value performed in the past?

The current Enterprise Value of Annexon, Inc. (ANNX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Annexon, Inc. (ANNX) Enterprise Value vs. Peers

How is ANNX’s Enterprise Value compared to its peers?

Annexon, Inc.’s Enterprise Value is greater than Immix Biopharma, Inc. (26.69M), greater than CNS Pharmaceuticals, Inc. (-250485.00), greater than Hepion Pharmaceuticals, Inc. (5.39M), greater than Freeline Therapeutics Holdings plc (2.82M), greater than AVROBIO, Inc. (-85302404.00), less than Day One Biopharmaceuticals, Inc. (945.30M), greater than Acumen Pharmaceuticals, Inc. (128.98M), greater than X4 Pharmaceuticals, Inc. (40.87M), greater than Inozyme Pharma, Inc. (192.45M), less than VectivBio Holding AG (848.58M), less than IVERIC bio, Inc. (5.13B), less than Blueprint Medicines Corporation (6.39B), greater than Amylyx Pharmaceuticals, Inc. (304.31M), less than Karuna Therapeutics, Inc. (12.43B), less than Arcus Biosciences, Inc. (1.30B), less than Cullinan Oncology, Inc. (643.93M), less than Structure Therapeutics Inc. (1.76B), less than Relay Therapeutics, Inc. (694.20M), greater than Zura Bio Limited (8.31M), less than Icosavax, Inc. (713.87M), greater than IN8bio, Inc. (23.94M), less than Wave Life Sciences Ltd. (1.98B),

Build a custom stock screener for Annexon, Inc. (ANNX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Annexon, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Annexon, Inc. (ANNX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Annexon, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.